Back
Summit Therapeutics Stock Price Chart
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
33
SMMT
Summit Therapeutics
Last Price:
$21.53
Seasonality Move:
-4.4%
7 Day Trial
ALL ACCESS PASS
$
7
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing slight buying pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.09 | Sell |
| 20-day SMA: | 23.17 | Sell |
| 50-day SMA: | 23.29 | Sell |
| 200-day SMA: | 20.4 | Buy |
| 8-day EMA: | 21.02 | Sell |
| 20-day EMA: | 22.55 | Sell |
| 50-day EMA: | 22.86 | Sell |
| 200-day EMA: | 19.23 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 43.57 | Sell |
| Chaikin Money Flow: | 453420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.95 - 26.43) | Sell |
| Bollinger Bands (100): | (18.46 - 25.14) | Sell |
Summit Therapeutics Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 20.59 while SMMT 8-day simple moving average is 21.09, which is a Sell signal.
-
The stock price of SMMT is 20.59 while Summit Therapeutics 20-day SMA is 23.17, which makes it a Sell.
-
Summit Therapeutics 50-day simple moving average is 23.29 while SMMT share price is 20.59, making it a Sell technically.
-
SMMT stock price is 20.59 and Summit Therapeutics 200-day simple moving average is 20.40, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
33
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a SellThe current Summit Therapeutics [SMMT] share price is $20.59. The Score for SMMT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
15.3B
Price in USD:
20.59
Share Volume:
3.9M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
6.78
Sell
33
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 20.59 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 20.59 while SMMT 8-day exponential moving average is 21.02, which is a Sell signal.
-
The stock price of SMMT is 20.59 while Summit Therapeutics 20-day EMA is 22.55, which makes it a Sell.
-
Summit Therapeutics 50-day exponential moving average is 22.86 while SMMT share price is 20.59, making it a Sell technically.
-
SMMT stock price is 20.59 and Summit Therapeutics 200-day simple moving average is 19.23, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is -1.12, suggesting Summit Therapeutics is a Sell
-
Summit Therapeutics Relative Strength Index (RSI) is 43.57, which suggest Summit Therapeutics is oversold
-
The Bollinger Bands (25) for Summit Therapeutics is (20.95 - 26.43), which suggest Summit Therapeutics is a Sell
-
The Bollinger Bands (100) for Summit Therapeutics is (18.46 - 25.14), which suggest Summit Therapeutics is a Sell
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.